Gwanin Shark

Wadatacce

• Da alama ba shi da tasiri ga ...
• Evidencearancin shaida don kimanta inganci don ...
• Kariya & Gargaɗi na Musamman:

Gwanin Shark (nama mai tauri wanda ke ba da tallafi, kamar yadda kashi yake) wanda ake amfani da shi don magani ya fito ne daga sharks da aka kama a Tekun Pacific. Yawancin nau'ikan ruwan 'ya'ya ana yin su ne daga guringuntsi na shark ciki har da squalamine lactate, AE-941, da U-995.

Girman gishirin Shark an fi amfani da shi sosai don cutar kansa. Hakanan ana amfani da gagarin Shark don cutar osteoarthritis, cututtukan psoriasis, rashin gani da suka shafi shekaru, warkar da rauni, lalata kwayar ido ta ido saboda ciwon suga, da kumburin hanji (enteritis).

Wasu mutane suna amfani da guringuntsi na shark kai tsaye zuwa fata don amosanin gabbai da cutar psoriasis.

Wasu mutane suna sanya guringuntsi shark a cikin dubura don cutar kansa.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don SHARK KYAUTA sune kamar haka:

Da alama ba shi da tasiri ga ...

• Ciwon daji. Mafi yawan bincike ya nuna cewa shan guringuntsi mai daukar kifin a baki ba ya amfanar da mutanen da ke fama da cutar kansa ta nono, ta hanji, huhu, ta prostate, ko ta kwakwalwa. Hakanan ba ze amfanar da mutane tare da ci gaba ba, wanda aka kula dashi a baya wanda ba Hodgkin's lymphoma. Ba a yi nazarin guringuntsi na Shark a cikin mutanen da ke fama da cutar kansa ba.

Evidencearancin shaida don kimanta inganci don ...

• Ciwon daji wanda ake kira Kaposi sarcoma. Akwai rahotanni cewa sanya guringuntsi mai daukar kifin a jikin fata na iya rage ciwan da ake kira Kaposi sarcoma. Wadannan cututtukan sun fi yawa ga mutanen da ke dauke da kwayar cutar HIV.
• Osteoarthritis. Lokacin amfani da fata, samfuran da ke ƙunshe da guringuntsi na 'shark' a haɗe da sauran abubuwan haɗin suna bayar da rahoton rage alamun cututtukan arthritis. Koyaya, duk wani sauƙin taimako na alama shine mafi ƙarancin sinadarin kafur ba sauran abubuwan ba. Bugu da ƙari, babu wani bincike da ke nuna cewa guringuntsi mai ɗaukar kifin yana shan fata.
• Psoriasis. Bincike na farko a cikin mutanen da ke dauke da almarar psoriasis ya nuna cewa takamaiman ƙarancin guringuntsi (AE-941) yana inganta bayyanar alamomi kuma yana rage ƙaiƙayi lokacin ɗauka ta baki ko amfani da fata.
• Wani nau'in kansar koda da ake kira koda cell carcinoma. Samun takamaiman gishirin kifin kifin (AE-941) na baki na iya kara rayuwa a cikin marasa lafiya da kwayar cutar sankara.
• Rashin hangen nesa mai alaka da shekaru.
• Raunin rauni.
• Sauran yanayi.

Ana buƙatar ƙarin shaida don kimanta guringuntsi mai kaifin kifin don waɗannan amfani.

Girman gishirin Shark na iya hana haɓakar sabbin jijiyoyin jini da ake buƙata don ciwon kansa ya yi girma. Hakanan yana iya hana ci gaban jijiyoyin jini zuwa raunin psoriasis. Wannan na iya taimakawa warkar da waɗannan raunuka.

Shark guringuntsi ne MALAM LAFIYA ga mafi yawan mutane idan aka sha su da bakinsu har na tsawon watanni 40 ko kuma idan aka shafa a fata har zuwa makonni 8.

Yana iya haifar da mummunan ɗanɗano a cikin baki, tashin zuciya, amai, tashin hankali na ciki, maƙarƙashiya, ƙarancin jini, jiri, hawan jini, yawan ƙwayoyin calcium, rauni, da kasala. Hakanan yana iya haifar da lalacewar hanta. Wasu samfuran suna da ƙanshin mara daɗi da dandano.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Babu isasshen bayani gamsasshe game da amincin ɗaukar guringuntsi na shark idan kuna da ciki ko ciyar da nono. Kasance a gefen aminci ka guji amfani.

"Cututtukan kansa" kamar su sclerosis da yawa (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), ko wasu yanayi: Girman gishirin Shark na iya haifar da tsarin garkuwar jiki ya zama mai aiki sosai. Wannan na iya ƙara alamun alamun cututtukan autoimmune. Idan kana da ɗayan waɗannan sharuɗɗan, zai fi kyau ka guji amfani da guringuntsi mai kifin 'shark'.

Babban matakan calcium (hypercalcemia): Girman gishiri na Shark na iya kara yawan sinadarin, saboda haka bai kamata mutane masu amfani da alli sun riga sun yi yawa ba.

Matsakaici

Yi hankali da wannan haɗin.

Magunguna waɗanda ke rage tsarin garkuwar jiki (Immunosuppressants)

Girman gishirin Shark na iya ƙara tsarin garkuwar jiki. Ta hanyar kara karfin garkuwar jiki, guringuntsi shark na iya rage tasirin magungunan da ke rage garkuwar jiki.

Wasu magungunan da ke rage garkuwar jiki sun hada da azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK50, ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), da sauransu.

Alli

Girman gishirin Shark na iya tayar da matakan alli. Akwai damuwa cewa amfani da shi tare da abubuwan ƙoshin alli na iya sa matakan calcium sun yi yawa.

Ruwan 'ya'yan itace

Ruwan 'ya'yan itace na Acidic kamar su lemu, apple, innabi, ko tumatir, na iya rage karfin guringuntsi shark yayin da mintuna suka wuce. Idan an saka guringuntsi na shark a cikin ruwan 'ya'yan itace, ya kamata a ƙara shi daidai kafin amfani.

Halin da ya dace na guringuntsi na shark ya dogara da dalilai da yawa kamar shekarun mai amfani, lafiya, da sauran yanayi da yawa. A wannan lokacin babu isasshen bayanan kimiyya don ƙayyade madaidaitan allurai don guringuntsi. Ka tuna cewa kayan halitta ba koyaushe suna da aminci ba kuma ƙididdigar na iya zama mahimmanci. Tabbatar da bin kwatancen dacewa akan alamun samfuran kuma tuntuɓi likitan ku ko likita ko wasu ƙwararrun likitocin kiwon lafiya kafin amfani.

AE-941, Cartilage de Requin, Cartilage de Requin du Pacifique, Cartilago de Tiburon, Collagène Marin, Extrait de Cartilage de Requin, Liquide de Cartilage Marin, Marine Collagen, Marine Liquid Cartilage, MSI-1256F, Neovastat, Pacific Shark Cartige, de Cartilage de Requin, Shark Cartilage Powder, Shark Cartilage Cire, Sphyrna lewini, Squalus acanthias.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.

1. Merly L, Smith SL. Abubuwan haɓaka mai kumburi na ƙarancin guringuntsi na shark. Immunopharmacol Immunotoxicol. 2015; 37: 140-7. Duba m.
2. Sakai S, Otake E, Toida T, Goda Y. Tabbatar da asalin chondroitin sulfate a cikin "abinci mai lafiya". Chem Pharm Bull (Tokyo). 2007; 55: 299-303. Duba m.
3. PDQ Hadakarwa, Madadin, da kuma Karin Bayani na Editan Edita. Guringuntsi (Bovine da Shark) (PDQ®): Sanarwar Kwarewar Kiwon Lafiya. Takaitattun Bayanin Bayanin Ciwon PDQ [Intanet]. Bethesda (MD): Cibiyar Cancer ta Kasa (US); 2002. 2016 Jul 21. Duba m.
4. Goldman E. Shark guringuntsi cire kokarin kamar yadda wani labari psoriasis magani. Skin Duk Labaran 1998; 29: 14.
5. Gudanar da Abinci da Magunguna. FDA ta ɗauki mataki kan kamfanonin sayar da magunguna da ba a yarda da su ba. Takardar magana ta FDA (Disamba 10, 1999)
6. Lane W da Milner M. A kwatancen ƙarancin kifin kifin kifin 'shark' da guringuntsi. Townsend Lett 1996; 153: 40-42.
7. Zhuang, L, Wang, B, Shivji, G, da sauransu. AE-941, mawallafin mai hana maganin angiogenesis yana da tasiri mai tasiri game da cutar kumburi akan saduwa da mutum. J Jarin Kasuwanci 1997; 108: 633.
8. Turcotte P. Phase I na haɓaka nazarin nazarin AE-941, wani wakilin antiangiogenic, a cikin haƙuri mai alaƙa da cutar rashin lafiya. Taron inaungiyar Retina (Hawaii, Disamba 2, 1999).
9. Saunder DN. Angiogenesis antagonist a matsayin magani ga psoriasis: Sakamakon gwajin gwaji na Farko na I tare da AE-941. Cibiyar Nazarin Ilimin Lafiyar Amurka, New Orleans, Louisiana, Maris 19-24, 1999.
10. Aeterna dakunan gwaje-gwaje Inc. Tsarin lokaci na III binciken bazuwar AE-941 (Neovastat; Shark Cartilage Cire) a cikin marasa lafiya tare da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta. 2001.
11. Escudier, B, Patenaude, F, Bukowski, R, da et al. Dalili don gwajin gwaji na lokaci na III tare da AE-941 (Neovastat (R)) a cikin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta. Ann Oncol 2000; 11 (ƙarin 4): 143-144.
12. Dupont E, Alaoui-Jamali M, Wang T, da sauransu. Ayyukan Angiostatic da antitumoral na AE-941 (Neovastat), wani ɓangaren kwayoyin da aka samu daga guringuntsi na shark. Ayyukan Associationungiyar (asar Amirka na Nazarin Ciwon daji 1997; 38: 227.
13. Shimizu-Suganuma, Masum, Mwanatambwe, Milanga, Iida, Kazum, da sauransu. Hanyoyin guringuntsi shark akan ciwan ƙari da lokacin rayuwa a cikin rayuwa (taron ganawa). Pron Annu Gana Am Soc Clin Oncol 1999; 18: A1760.
14. Ba a sani ba. Ayyukan Angiostatic da antitumoral na AE-941 (neovastat-R), wani ɓangaren kwayoyin da aka samo daga guringuntsi na shark (taron gamuwa). Pro Annu Gana Am Assoc Ciwon Cancer Res 1997; 38: A1530.
15. Cataldi, JM da Osborne, DL. Hanyoyin guringuntsi na shark akan ƙwayar mammary neovascularization a cikin rayuwa da yaduwar kwayar halitta a cikin vitro (taron ganawa). Jaridar FASEB 1995; 9: A135.
16. Jamali MA, Riviere P, Falardeau A, da et al. Tasirin AE-941 (Neovastat), mai hana angiogenesis, a cikin ƙirar ƙirar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta dake cikin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ta ƙwayoyin cuta ta kwayar cutar, ta hanyar amfani da inganci, da rigakafin guba da rayuwa. Clin Invest Med 1998; (samar): S16.
17. Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, da Dupont E. Phase I / II na gwaji akan AE-941 (Neovastat) a cikin marasa lafiya da ke fama da cutar ƙanƙarawar prostate (gabatarwa ta gaba). Taron shekara-shekara na Urological Association na Kanada (24-27 ga Yuni, 2001).
18. Rosenbluth, RJ, Jennis, AA, Cantwell, S, da et al. Gwanin baka na shark a cikin maganin marasa lafiya tare da ciwan ƙwaƙwalwar ƙwaƙwalwar farko. Nazarin matukin jirgi na zamani (ganawa na ƙarshe). Pron Annu Gana Am Soc Clin Oncol 1999; 18: A554.
19. Dupont E, Savard RE, Jourdain C, Juneau C, Thibodeau A, Ross N, da et al. Abubuwan antiangiogenic na wani sabon abu mai ɗauke da ƙarancin kifin shark: rawar da za a taka a maganin psoriasis. J Cutan Med Surg 1998; 2: 146-152.
20. Lane IW da Contreras E. rateimar yawan aiki na rayuwa (raguwa a cikin babban ƙwayar cuta) wanda aka lura a cikin marasa lafiya masu fama da cutar kansa waɗanda aka kula da su da kayan guringuntsi. J Naturopath Med 1992; 3: 86-88.
21. Wilson JL. Gangar jikin mai yatsu da keɓaɓɓiyar fata ta shawo kan cutar psoriasis. Sauran Comp Ther 2000; 6: 291.
22. Riviere M, Latreille J, da Falardeau P. AE-941 (Neovastat), mai hana angiogenesis: sakamakon gwajin gwaji na asibiti I / II. Ciwon daji Cancer 1999; 17 (samar da 1): 16-17.
23. Milner M. Jagora ga yin amfani da guringuntsi shark a cikin maganin cututtukan zuciya da sauran cututtukan haɗin gwiwa masu kumburi. Amer Chiropractor 1999; 21: 40-42.
24. Leitner SP, Rothkopf MM, Haverstick DD, da et al. Nazarin lokaci na II na II game da busassun busassun ƙurar ƙura (SCP) a cikin marasa lafiya tare da ko dai nono mai haɗari ko ƙwarƙwarar ƙwayar ƙwayar ƙwayar ƙwayar cuta zuwa daidaitaccen magani. Amer Soc Clin Oncol 1998; 17: A240.
25. Evans WK, Latreille J, Batist G, da et al. AE-941, mai hana angiogenesis: ma'ana don ci gaba a hade tare da shigar da cutar sankarar iska / radiotherapy a cikin marasa lafiya da ƙananan ƙananan ƙwayoyin huhu (NSCLC). Takardun da aka Samu 1999; S250.
26. Riviere M, Falardeau P, Latreille J, da et al. Sakamakon gwajin gwaji na I / II na gwajin cutar huhu tare da AE-941 (Neovastat ®) mai hana angiogenesis. Clin Invest Med (kari) 1998; S14.
27. Riviere M, Alaoui-Jamali M, Falardeau P, da et al. Neovastat: mai hana angiogenesis tare da aikin anti-cancer. Pro Amer Assoc Ciwon Cutar Res 1998; 39: 46.
28. Babu marubuta Neovastat gwajin gwaji abstracts. 2001;
29. Nazarin Aeterna Laboratories Inc. Karatun II na AE-941 (Neovastat; Shark Cartilage) a cikin marasa lafiya tare da sake dawowa da wuri ko ƙin yawan myeloma. 2001. Lambar Saduwa da Bayani 1-888-349-3232.
30. Felzenszwalb, I., Pelielo de Mattos, J. C., Bernardo-Filho, M., da Caldeira-de-Araujo, A. Shark guringuntsi mai ɗauke da shiri: kariya daga nau'in oxygen masu aiki. Abincin Chem Toxicol 1998; 36: 1079-1084. Duba m.
31. Coppes, M. J., Anderson, R. A., Egeler, R. M., da Wolff, J. E. Sauran hanyoyin magance cutar kansa na yara. N Engl. J Med 9-17-1998; 339: 846-847. Duba m.
32. Davis, P. F., He, Y., Furneaux, R.H, Johnston, P. S., Ruger, B. M., da Slim, G. C An dakatar da angiogenesis ta hanyar amfani da bakin kifin a cikin ƙirar ƙira. Microvasc.Res 1997; 54: 178-182. Duba m.
33. McGuire, R. Magunguna na 1996; 16: 237-244. Duba m.
34. Kuettner, K. E. da Pauli, B. U. Haramtawa neovascularization ta hanyar guringuntsi factor. Ciba Aka Samu. 1983; 100: 163-173.Duba m.
35. Lee, A. da Langer, R. Shark guringuntsi ya ƙunshi masu hana ƙwayar angiogenesis. Kimiyya 9-16-1983; 221: 1185-1187. Duba m.
36. Korman, D. B. [Antiangiogenic da antitumor Properties na guringuntsi]. Vopr.Onkol. 2012; 58: 717-726. Duba m.
37. Patra, D. da Sandell, L. J. Antiangiogenic da kwayoyin antiancer a cikin guringuntsi. Kwararre. Rev Mol.Med 2012; 14: e10. Duba m.
38. de Mejia, E. G. da Dia, V. P. Matsayin sunadarai masu gina jiki da peptides a cikin apoptosis, angiogenesis, da metastasis na kwayoyin cutar kansa. Ciwon Cancer Metastasis Rev 2010; 29: 511-528. Duba m.
39. Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., da Safari, E. Sakamakon tasirin guringuntsi mai yalwar furotin akan ƙwayoyin NK. Immunopharmacol. Imunotoxicol. 2011; 33: 403-409. Duba m.
40. Lee, S. Y. da Chung, S. M. Neovastat (AE-941) sun hana kumburin iska ta hanyar VEGF da danniya na HIF-2. Vascul. Pharmacol 2007; 47 (5-6): 313-318. Duba m.
41. Pearson, W., Orth, M. W., Karrow, N. A., Maclusky, N. J., da Lindinger, M. I. Anti-mai kumburi da cututtukan cututtukan kwayoyi daga Sasha's Blend a cikin guntun kayan kwalliya mai bayanin kumburi. Mol Nutr Abincin Abincin 2007; 51: 1020-1030. Duba m.
42. Kim, S., de, A., V, Bouajila, J., Dias, AG, Cyrino, FZ, Bouskela, E., Costa, PR, da Nepveu, F. Alpha-phenyl-N-tert-butyl nitrone ( PBN) abubuwanda suka samo asali: kira da kuma aikin kariya daga cutarwar kwayar halitta ta hanyar ischemia / reperfusion. Bioorg.Med Chem 5-15-2007; 15: 3572-3578. Duba m.
43. Merly, L., Simjee, S., da Smith, S. L. shigar da cututtukan cytokines masu kumburi ta hanyar cirewa guringuntsi. Int Immunopharmacol. 2007; 7: 383-391. Duba m.
44. Musa, M. A., Sudhalter, J., da Langer, R. Gano wani mai hana neovascularization daga guringuntsi. Kimiyya 6-15-1990; 248: 1408-1410. Duba m.
45. Ratel, D., Glazier, G., Provencal, M., Boivin, D., Beaulieu, E., Gingras, D., da Beliveau, R. enzymes na fibrinolytic masu aiki kai tsaye a cikin gutsun jikin kifin: cuta. YankinRes. 2005; 115 (1-2): 143-152. Duba m.
46. Gingras, D., Labelle, D., Nyalendo, C., Boivin, D., Demeule, M., Barthomeuf, C., da Beliveau, R. Wakilin antiangiogenic Neovastat (AE-941) yana motsa ayyukan plasminogen activator. Sanya Sabon Magunguna 2004; 22: 17-26. Duba m.
47. Latreille, J., Batist, G., Laberge, F., Champagne, P., Croteau, D., Falardeau, P., Levinton, C., Hariton, C., Evans, WK, da Dupont, E. Phase Gwajin I / II na aminci da ingancin AE-941 (Neovastat) a cikin maganin ƙananan ƙwayoyin cuta na huhu. Ciwon Cutar Sankara 2003; 4: 231-236. Duba m.
48. Bukowski, R. M. AE-941, mahaɗar antiangiogenic mai fa'ida: gwaji a cikin ƙwayar sankarar ƙwayoyin cuta. Kwararre. Opin. Investig.Drugs 2003; 12: 1403-1411. Duba m.
49. Jagannath, S., Champagne, P., Hariton, C., da Dupont, E. Neovastat a cikin myeloma da yawa. Eur.J.Haematol. 2003; 70: 267-268. Duba m.
50. FDA ta ba da matsayin marayan-magani na Neovastat na Aeterna don cutar kansa. Kwararre. Rev Anticancer Ther 2002; 2: 618. Duba m.
51. Dupont, E., Falardeau, P., Mousa, SA, Dimitriadou, V., Pepin, MC, Wang, T., da Alaoui-Jamali, MA Antiangiogenic da antimetastatic Properties na Neovastat (AE-941), mai ci gaba da aiki da baki samu daga guringuntsi nama. Clin Exp Metastasis 2002; 19: 145-153. Duba m.
52. Beliveau, R., Gingras, D., Kruger, EA, Lamy, S., Sirois, P., Simard, B., Sirois, MG, Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, MC, Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, WD, da Dupont, E. Wakilin Antiangiogenic Neovastat (AE-941) Yana hana Ci Gaban Endananan otheananan orananan -daidaita Illolin Halittu. Ciwon Cutar Sankara 2002; 8: 1242-1250. Duba m.
53. Weber, M. H., Lee, J., da Orr, F. W. Sakamakon Neovastat (AE-941) akan samfurin ƙwayar ƙwayar ƙashi ta gwaji. Int J Oncol 2002; 20: 299-303. Duba m.
54. Barber, R., Delahunt, B., Grebe, S. K., Davis, P. F., Thornton, A., da Slim, G. C. Gasar gwal na baka ba ta kawar da kwayar cutar kanjamau amma tana jinkirta ci gaban tumor a cikin samfurin murine. Maganin Anticancer Res 2001; 21 (2A): 1065-1069. Duba m.
55. Gonzalez, RP, Soares, FS, Farias, RF, Pessoa, C., Leyva, A., Barros Viana, GS, da Moraes, MO Nunin tasirin hanawa na guringuntsi na kifin na shark akan ainihin haɓakar haɓakar fibroblast da ke haifar da angiogenesis a cikin zomo cornea. Biol.Pharm.Bull. 2001; 24: 151-154. Duba m.
56. Brem, H. da Folkman, J. Tsarin hana angiogenesis wanda aka daidaita shi ta hanyar guringuntsi. J Bay.Med 2-1-1975; 141: 427-439. Duba m.
57. Koch, A. E. Matsayin angiogenesis a cikin cututtukan zuciya na rheumatoid: abubuwan da suka faru kwanan nan. Ann Rheum. 2000; 59 Gudanar da 1: i65-i71. Duba m.
58. Tattaunawa, K. L. da Harris, A. L. Matsayi na yanzu game da abubuwan antiangiogenic. Br J Haematol. 2000; 109: 477-489. Duba m.
59. Morris, G. M., Coderre, J. A., Micca, P. L., Lombardo, D. T., da Hopewell, J. W. Boron magani ne na kamala na bera na 9L gliosarcoma: kimantawa game da tasirin kifin kifin. Br J Radiol. 2000; 73: 429-434. Duba m.
60. Renckens, C. N. da van Dam, F. S. [Asusun ciwon daji na ƙasa (Koningin Wilhelmina Fonds) da Houtsmuller-therapy don cutar kansa]. Ned.Tijdschr.Geneeskd. 7-3-1999; 143: 1431-1433. Duba m.
61. Musa, MA, Wiederschain, D., Wu, I., Fernandez, CA, Ghazizadeh, V., Lane, WS, Flynn, E., Sytkowski, A., Tao, T., da Langer, R. Troponin I shine yanzu a cikin guringuntsi na ɗan adam kuma yana hana angiogenesis. Kamfanin Natl. Cad. Sci USA 3-16-1999; 96: 2645-2650. Duba m.
62. Moller HJ, Moller-Pedersen T, Damsgaard TE, Poulsen JH. Nunin keratin sulphate na rigakafi a cikin chondroitin 6-sulfate na kasuwanci daga guringuntsi. Abubuwan da ke faruwa ga gwajin ELISA. Dokar Chim Acta 1995; 236: 195-204. Duba m.
63. Lu C, Lee JJ, Komaki R, et al. Chemoradiotherapy tare da ko ba tare da AE-941 a cikin mataki na III ƙananan ƙananan ƙwayoyin cuta na huhu ba: gwajin bazuwar lokaci na III. J Cutar Cancer Inst 2010; 102: 1-7. Duba m.
64. Loprinzi CL, Levitt R, Barton DL, et al. Kimantawa game da guringuntsi a cikin marasa lafiya masu fama da cutar kansa: gwajin Groupungiyar Kula da Ciwon Cancer ta Arewa ta Tsakiya. Ciwon daji 2005; 104: 176-82. Duba m.
65. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) a cikin ƙananan ƙwayoyin carcinoma marasa lafiya: rahoto game da gwajin lokaci na II tare da matakan kashi biyu. Ann Oncol 2002; 13: 1259-63 .. Duba m.
66. Sauder DN, Dekoven J, Champagne P, et al. Neovastat (AE-941), mai hana angiogenesis: Yanayin gwaji na I / II na gwajin gwaji ya haifar da marasa lafiya tare da allon psoriasis. J Am Acad Dermatol 2002; 47: 535-41. Duba m.
67. Gingras D, Renaud A, Mousseau N, et al. Matrix ta hana AE-941, wani sinadarin antiangiogenic mai yawan aiki. Anticancer Res 2001; 21: 145-55 .. Duba m.
68. Falardeau P, Champagne P, Poyet P, et al. Neovastat, wani magani mai saurin yaduwar cutar antiangiogenic, a cikin gwajin gwajin lokaci na III. Semin Oncol 2001; 28: 620-5 .. Duba m.
69. Boivin D, Gendron S, Beaulieu E, et al. Wakilin antiangiogenic Neovastat (AE-941) yana haifar da apoptosis cell endothelial. Mol Cancer Ther 2002; 1: 795-802 .. Duba m.
70. Cohen M, Wolfe R, Mai T, Lewis D. Wani baƙaƙen, makafi biyu, gwajin gwaji na wuribo na maganin shafawa wanda ke ɗauke da glucosamine sulfate, chondroitin sulfate, da kuma kafur don osteoarthritis na gwiwa. J Rheumatol 2003; 30: 523-8 .. Duba m.
71. May B, Kuntz HD, Kieser M, Kohler S. Inganci na tsayayyen man ruhun nana / caraway mai haɗuwa a cikin cutar rashin ciwo. Arzneimittelforschung 1996; 46: 1149-53. Duba m.
72. Anon. AEterna ta sanar da fara rajistar masu haƙuri don gwajin gwaji na III na gwajin cutar ta AH-941 / Neovastat na NIH - wanda ke ɗaukar nauyi a cikin maganin sankarar huhu. Sanarwar News na Aeterna 2000 2000 Mayu 17.
73. Sheu JR, Fu CC, Tsai ML, Chung WJ. Tasirin U-995, mai hana mai ɗauke da ƙwayoyin cuta mai ɗauke da ƙwayoyin cuta, akan ayyukan angiogenesis da anti-tumo. Maganin Anticancer Res 1998; 18: 4435-41. Duba m.
74. Fontenele JB, Viana GS, Xavier-Filho J, de-Alencar JW. Anti-mai kumburi da aikin analgesic na ruwa mai narkewa daga guringuntsi shark. Braz J Med Biol Res 1996; 29: 643-6. Duba m.
75. Fontenele JB, Araujo GB, de Alencar JW, Viana GS. Hanyoyin motsa jiki da cututtukan cututtukan ƙwayoyin cuta na shark ne saboda kwayar peptide kuma suna dogara da tsarin nitric oxide (NO). Biol Pharm Bull 1997; 20: 1151-4. Duba m.
76. Gomes EM, Souto PR, Felzenszwalb I. Shark-guringuntsi wanda ya ƙunshi shiri yana kare ƙwayoyin halitta daga haɓakar hydrogen peroxide da lalacewar mutagenesis. Mutat Res 1996; 367: 204-8. Duba m.
77. Mathews J. Media yana jin haushi game da guringuntsi a matsayin maganin kansa. J Cutar Cancer Inst 1993; 85: 1190-1. Duba m.
78. Bhargava P, Trocky N, Marshall J, et al. Tsaro na lokaci na 1, haƙuri da nazarin ilimin magani na haɓakar haɓaka, haɓakar ci gaba na ci gaba na MSI-1256F (Squalamine Lactate) a cikin marasa lafiya da ke fama da cutar kansa. Proc Am Soc Clinical Oncol 1999; 18: A698.
79. Kalidas M, Hammond LA, Patnaik P, et al. Nazarin lokaci na 1 da nazarin magunguna (PK) na mai hana angiogenesis, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 2000; 19: A698.
80. Patnaik A, Rowinsky E, Hammond L, et al. Nazarin lokaci na 1 da nazarin magunguna (PK) na musamman mai hana hana angiogenesis, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 1999; 18: A622.
81. Evans WK, Latreille J, Batist G, et al. AE-941, mai hana angiogenesis: ma'ana don ci gaba a hade tare da shigar da cutar sankarar iska / radiotherapy a cikin marasa lafiya da ƙananan ƙananan ƙwayar huhu (NSCLC). Proc Am Soc Clinical Oncol 1999; 18: A1938.
82. Rosenbluth RJ, Jennis AA, Cantwell S, DeVries J. Oral shark guringuntsi a cikin kula da marasa lafiya tare da ci gaba na ciwan kwakwalwa. Nazarin matuki na zamani. Proc Am Soc Clinical Oncol 1999; 18: A554.
83. Leitner SP, Rothkopf MM, Haskoki L, et al. Nazarin lokaci na II na biyu game da busassun busassun kifin (SCP) a cikin marasa lafiya (pts) tare da ko ƙwayar nono mai cike da ƙwayar cuta ko ƙin yarda da cutar sankarar ƙugu. Proc Am Soc Clinical Oncol 1998; 17: A240.
84. Cibiyar Cancer ta NatlNet. Gizon gidan gwari: www.cancer.gov (An shiga 18 Agusta 2000).
85. Berbari P, Thibodeau A, Germain L, et al Antiangiogenic sakamako na baka gudanar da ruwa guringuntsi cire a cikin mutane. J Surg Res 1999; 87: 108-13. Duba m.
86. Hillman JD, Peng AT, Gilliam AC, Remick SC. Jiyya na Kaposi Sarcoma tare da gudanar da baka na gandun daji na shark a cikin kwayar cutar Herpes ta mutum 8-seropositive, Iman Adam da ke munarfafa munwayar cuta-Seronegative ɗan kishili. Arch Dermatol 2001; 137: 1149-52. Duba m.
87. Neovastat gwajin gwaji abstracts. An gabatar dashi a Americanungiyar Americanungiyar Americanasar ta Amirka don Nazarin Cancer na shekara ta 92nd. Maris 27, 2001.
88. Wilson JL. Gwajin kifin kifin kifin na shark ya rinjayi psoriasis: bita da bincike da kuma sakamakon asibiti na farko. Sauran Thearin rari 2000; 6: 291.
89. Miller DR, Anderson GT, Stark JJ, et al. Sauran abubuwa Lokaci na I / II na gwaji na aminci da inganci na guringuntsi shark a maganin babban ciwon daji. J Jarin Oncol 1998; 16: 3649-55. Duba m.
90. Lane IW, Comac L. Sharks ba sa samun cutar kansa. Garden City, NY: Kungiyar Avery Publishing; 1992.
91. Farauta TJ, Connelly JF. Girman guringuntsi na Shark don maganin ciwon daji. Am J Lafiya Syst Pharm 1995; 52: 1756-60. Duba m.
92. Ashar B, Vargo E. Shark guringuntsi-ya haifar da hepatitis [wasika]. Ann Intern Med 1996; 125: 780-1. Duba m.

Reviewedarshen sake dubawa - 03/14/2019